Nachrichten

Aktie

ISIN: SE0007577895 WKN: A14W4W Land Flagge SE

Schweden

Zur Watchlist hinzufügen Zum Portfolio hinzufügen

Zum Portfolio hinzufügen

0,9090

EUR

-1,94 %

-0,0180 EUR

Letzter Kurs 17.11.25 Lang & Schwarz

Vicore Pharma Holding Aktie kaufen

Geldkurs

17.11.25

0,8930

EUR

1.090 STK

Briefkurs

17.11.25

0,9250

EUR

1.090 STK

Neueste Nachrichten

Vicore to Present at The Jefferies Global Healthcare Conference in London 17.11.25 · Accesswire · Vicore Pharma Holding
Vicore to Present at Upcoming Investor Conferences 05.11.25 · Accesswire · Vicore Pharma Holding
Interim Report July - September 2025 05.11.25 · Accesswire · Vicore Pharma Holding
Vicore Announces The Nomination Committee For The 2026 Annual General Meeting 03.11.25 · Accesswire · Vicore Pharma Holding
Buloxibutid Receives Orphan Drug Designation in Japan for the Treatment of Idiopathic Pulmonary Fibrosis 30.09.25 · Accesswire · Vicore Pharma Holding
Vicore Announces Presentations at the European Respiratory Society Congress 2025 23.09.25 · Accesswire · Vicore Pharma Holding
Vicore to Present at Pareto Securities' 16th Annual Healthcare Conference 15.09.25 · Accesswire · Vicore Pharma Holding
Vicore to Present at Upcoming Investor Conferences 28.08.25 · Accesswire · Vicore Pharma Holding
Interim Report April - June 2025 22.08.25 · Accesswire · Vicore Pharma Holding
Increase in Number of Shares and Votes in Vicore Pharma 30.06.25 · Accesswire · Vicore Pharma Holding
Vicore to Present at the Jefferies Global Healthcare Conference 28.05.25 · Accesswire · Vicore Pharma Holding
Vicore Presents New Data at the 2025 American Thoracic Society International Conference 22.05.25 · Accesswire · Vicore Pharma Holding

Vicore to Present at The Jefferies Global Healthcare Conference in London 108 Leser

Vicore to Present at The Jefferies Global Healthcare Conference in London 108 Leser

Interim Report July - September 2025 116 Leser
Vicore Announces The Nomination Committee For The 2026 Annual General Meeting 112 Leser
Vicore to Present at Upcoming Investor Conferences 108 Leser
Vicore to Present at The Jefferies Global Healthcare Conference in London 108 Leser

Interim Report April - June 2025 228 Leser
Vicore to Present at the Nordea Equities Healthcare Seminar 220 Leser
Vicore Pharma Holding Year-End Report 2024 140 Leser
Increase in Number of Shares and Votes in Vicore Pharma 132 Leser
Vicore Announces Presentations at the European Respiratory Society Congress 2025 128 Leser
Vicore to Participate in the Van Lanschot Kempen Life Sciences Conference 128 Leser
Buloxibutid Receives Orphan Drug Designation in Japan for the Treatment of Idiopathic Pulmonary ... 120 Leser
Vicore Presents New Data at the 2025 American Thoracic Society International Conference 120 Leser
Bulletin from the Annual General Meeting of Vicore Pharma Holding AB (publ) 120 Leser
Interim Report January – March 2025 120 Leser